SI-BONE, Inc.·4

Jun 1, 5:47 PM ET

Davis Timothy E JR 4

4 · SI-BONE, Inc. · Filed Jun 1, 2026

Research Summary

AI-generated summary of this filing

Updated

SI‑BONE (SIBN) Director Timothy Davis Exercises Options and Sells Shares

What Happened
Timothy E. Davis Jr., a director of SI‑BONE, exercised stock options to acquire 12,064 shares on May 28, 2026, at an exercise price of $4.32 per share (total cash paid $52,116). Following the exercise, Davis sold a total of 7,280 shares in two open-market transactions (3,780 shares on 5/28 and 3,500 shares on 5/29) for aggregate proceeds of roughly $104,187.

Key Details

  • Filing date: 2026-06-01; Period of report lists transactions beginning 2026-05-28. The filing does not indicate a late filing.
  • Exercise: 12,064 shares at $4.32 per share; reported total paid $52,116. (Footnote F4: the option shares were fully vested and immediately exercisable.)
  • Sales: 3,780 shares on 2026-05-28 at a weighted average price of $14.47 (total ~$54,699; range $14.45–$14.505 per F1). 3,500 shares on 2026-05-29 at a weighted average price of $14.14 (total ~$49,488; range $14.12–$14.15 per F2). Aggregate sale proceeds ≈ $104,187.
  • The report also lists a derivative disposition of 12,064 shares at $0.00 (listed separately in the filing).
  • Ownership note (from filing footnote F3): reported beneficial ownership includes 8,675 shares issuable upon settlement of restricted stock units granted to the reporting person.

Context

  • This filing shows an option exercise (acquisition) followed by open‑market sales. The presence of both an exercise and subsequent sales can reflect a variety of routine actions (e.g., partial monetization or cash management); the filing itself does not state the insider’s motive.
  • For retail investors, purchases or exercises can be more informative than routine sales; here the insider did acquire shares via exercise but also realized proceeds from selling a portion of stock.

Insider Transaction Report

Form 4
Period: 2026-05-28
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-28$4.32/sh+12,064$52,11673,002 total
  • Sale

    Common Stock

    [F1]
    2026-05-28$14.47/sh3,780$54,69969,222 total
  • Sale

    Common Stock

    [F2][F3]
    2026-05-29$14.14/sh3,500$49,48865,722 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F4]
    2026-05-2812,0640 total
    Exercise: $4.32Exp: 2026-07-26Common Stock (12,064 underlying)
Footnotes (4)
  • [F1]This transaction was executed in multiple trades at prices ranging from $14.45 USD to $14.505 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]This transaction was executed in multiple trades at prices ranging from $14.12 USD to $14.15 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]Includes 8,675 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F4]The shares subject to the option are fully vested and immediately exercisable.
Signature
/s/ Michael A. Pisetsky, Attorney-in-Fact for Timothy E. Davis, Jr.|2026-06-01

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT